Congenital Cytomegalovirus Infection as a Cause of Sensorineural Hearing Loss in a Highly Immune Population
- 1 December 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 30 (12), 1043-1046
- https://doi.org/10.1097/inf.0b013e31822d9640
Abstract
Background: Antibodies to blood-stage Plasmodium falciparum antigens have been associated with protection against clinical malaria in some studies but not others. Many of these studies have not assessed whether high-titer antibodies are associated with protection and have not adjusted for differences in malaria exposure. Methods: The presence of high-titer antibodies to apical membrane antigen-1, erythrocyte-binding antigen-175 (EBA-175), and merozoite surface protein-119 (MSP-119) was assessed in 87 children living in a malaria holoendemic area of Kenya. The children were prospectively assessed during 1 year for clinical malaria. Results: In unadjusted analyses, high-titer antibodies to MSP-119, but not EBA-175 or apical membrane antigen-1, were associated with protection from clinical malaria. However, after adjustment for exposure, only high-titer antibodies to EBA-175 were associated with protection from clinical malaria (hazard ratio, 0.48; 95% confidence interval [CI], 0.24, 0.95; P = 0.03), and with reduced episodes of clinical malaria (incidence rate ratio, 0.50; 95% CI, 0.31, 0.81; P = 0.005). A trend toward increased protection from clinical malaria in children was seen with antibodies to both EBA-175 and MSP-119 (hazard ratio, 0.26; 95% CI, 0.03, 1.94; P = 0.18). Conclusions: High-titer antibodies to EBA-175 are associated with protection from clinical malaria in children in a malaria holoendemic area of Kenya. Accurate estimates of antibody-associated protection from clinical malaria require adjustment for malaria exposure.Keywords
This publication has 19 references indexed in Scilit:
- The universal newborn hearing screening in Brazil: From identification to interventionInternational Journal of Pediatric Otorhinolaryngology, 2010
- Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune PopulationClinical Infectious Diseases, 2009
- A 10-Year Prospective Study of Sensorineural Hearing Loss in Children with Congenital Cytomegalovirus InfectionThe Journal of Pediatrics, 2008
- Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?Journal of Clinical Virology, 2006
- Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunityThe Journal of Pediatrics, 2006
- Congenital cytomegalovirus (CMV) infection and hearing deficitJournal of Clinical Virology, 2006
- A united states national reference for fetal growthObstetrics & Gynecology, 1996
- Symptomatic congenital cytomegalovirus infectionThe Pediatric Infectious Disease Journal, 1992
- Congenital Cytomegalovirus Infection and Disease in Sweden and the Relative Importance of Primary and Secondary Maternal Infections: Preliminary Findings from a Prospective StudyScandinavian Journal of Infectious Diseases, 1984
- The Outcome in Children With Congenital Cytomegalovirus InfectionAmerican Journal of Diseases of Children, 1982